About
Voio, founded in 2025 in Berkeley, USA, builds a unified AI imaging reading and reporting platform (Pillar-0 model) to assist radiologists with multi-modality diagnosis.
Full tier & rationale — an SVTR Intelligence benefit
Capital graph
Investor· 2
Founders / team· 1
Funding history
- 2025-11Seed$9M
Investors · Laude Ventures, The House FundSource · SVTR Weekly #132 ↗
Comparable companies· by market
This company
BusinessLatest roundTotal raisedDate- Voio
Unified AI image reading and reporting platform (Pillar-0 model) to support radiology diagnosis across all modalities
Seed · $9M · 2025-11
$9M
United States
BusinessLatest roundTotal raisedDate- a2z Radiology AI
Unified multi-condition triage for abdominal-pelvic CT and radiology workflow AI
Seed · $5M · 2025-12
$5M - New Lantern
Uses AI to improve PACS, helping radiologists analyze medical images such as CT scans, MRI and X-rays
Series A · $19M · 2024-11
$19M - Ferrum Health
Platform that helps hospitals and medical centers integrate AI algorithms to support clinical tasks such as diagnosis, radiology and patient care
Undisclosed · $16M · 2024-09
$16M
China
BusinessLatest roundTotal raisedDateEurope
BusinessLatest roundTotal raisedDate- DESKi
AI tools that automatically analyze echocardiograms to assist heart disease diagnosis
Seed · $6M · 2025-06
$6M - Deepc
Integrates multiple AI tools into radiology workflows to help radiologists analyze medical images more efficiently
Series A · $13M · 2024-07
$13M - Raidium
AI-driven platform helping radiologists analyze medical images more efficiently
Undisclosed · $13M · 2024-12
$13M
Other / unspecified
BusinessLatest roundTotal raisedDate- NexusMD
AI agents that handle physicians' administrative tasks such as medical documentation and referrals
Seed · $4M · 2025-06
$4M - Blair Health
AI-assisted virtual care platform for menopause and midlife women's health
Pre-Seed · $3M · 2026-09
$3M - Scopia Surgical
AI surgical navigation software combining real-time spatial intelligence and patient-specific digital twins for robot-assisted and minimally invasive soft-tissue surgery
Pre-Seed · $3M · 2026-09
$3M
Confirmed rounds only. Matched on subsector, sector, stage and funding scale — each verifiable on the company profiles.
Investors that may fit
General Catalyst
40 Life Sciences deals in the last 24 months · 19 at a nearby stage · 36 in California
Request intro →Y Combinator
38 Life Sciences deals in the last 24 months · 26 at a nearby stage · 31 in California
Request intro →Andreessen Horowitz
24 Life Sciences deals in the last 24 months · 11 at a nearby stage · 22 in California
Request intro →Khosla Ventures
21 Life Sciences deals in the last 24 months · 7 at a nearby stage · 20 in California
Request intro →Thrive Capital
18 Life Sciences deals in the last 24 months · 3 at a nearby stage · 15 in California
Request intro →Lightspeed
17 Life Sciences deals in the last 24 months · 5 at a nearby stage · 15 in California
Request intro →Ranked by each firm’s deals in this sector over the last 24 months, weighted by nearby stage and shared geography. Indicative only — no rating judgment.